DE69925488D1 - Verwendung von fk506 und verwandten makroliden zur herstellung eines medikaments für die behandlung und vorbeugung von schmerzen - Google Patents
Verwendung von fk506 und verwandten makroliden zur herstellung eines medikaments für die behandlung und vorbeugung von schmerzenInfo
- Publication number
- DE69925488D1 DE69925488D1 DE69925488T DE69925488T DE69925488D1 DE 69925488 D1 DE69925488 D1 DE 69925488D1 DE 69925488 T DE69925488 T DE 69925488T DE 69925488 T DE69925488 T DE 69925488T DE 69925488 D1 DE69925488 D1 DE 69925488D1
- Authority
- DE
- Germany
- Prior art keywords
- pain
- medicament
- prevention
- manufacture
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9814640 | 1998-07-06 | ||
GBGB9814640.0A GB9814640D0 (en) | 1998-07-06 | 1998-07-06 | New use |
PCT/JP1999/003602 WO2000001385A1 (en) | 1998-07-06 | 1999-07-02 | Use of fk506 and related macrolides in the manufacture of a medicament for treatment or prevention of pain |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69925488D1 true DE69925488D1 (de) | 2005-06-30 |
DE69925488T2 DE69925488T2 (de) | 2005-11-17 |
Family
ID=10835037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69925488T Expired - Fee Related DE69925488T2 (de) | 1998-07-06 | 1999-07-02 | Verwendung von fk506 und verwandten makroliden zur herstellung eines medikaments für die behandlung und vorbeugung von schmerzen |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1093371B1 (de) |
JP (1) | JP2002519378A (de) |
DE (1) | DE69925488T2 (de) |
ES (1) | ES2239446T3 (de) |
GB (1) | GB9814640D0 (de) |
WO (1) | WO2000001385A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
EP1594484A2 (de) * | 2003-02-17 | 2005-11-16 | Cipla Ltd. | Pharmazeutisches pflaster |
WO2008083169A2 (en) | 2006-12-26 | 2008-07-10 | The Johns Hopkins University | Compositions and methods for the treatment of immunologic disorders |
AU2007339762B2 (en) | 2006-12-27 | 2011-03-31 | The Johns Hopkins University | Compositions and methods for treating inflammation and auto-immune diseases |
US7989173B2 (en) | 2006-12-27 | 2011-08-02 | The Johns Hopkins University | Detection and diagnosis of inflammatory disorders |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
KR20100051829A (ko) | 2007-07-31 | 2010-05-18 | 리머릭 바이오파르마 인코오포레이티드 | 인산화된 피론 유사체 및 방법 |
AU2010286361A1 (en) | 2009-08-31 | 2012-03-15 | Amplimmune, Inc. | Methods and compositions for the inhibition of transplant rejection |
US20130209463A1 (en) | 2010-06-30 | 2013-08-15 | Compugen Ltd. | Polypeptides and uses thereof as a drug for treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders |
EP2726503B1 (de) | 2011-06-30 | 2019-09-04 | Compugen Ltd. | Polypetide und ihre verwendung zur behandlung von autoimmunerkrankungen und infektionen |
WO2013155493A1 (en) | 2012-04-12 | 2013-10-17 | Yale University | Methods of treating inflammatory and autoimmune diseases and disorders |
JP2016505843A (ja) | 2012-12-19 | 2016-02-25 | アンプリミューン, インコーポレイテッド | B7−h4特異的抗体、並びにその組成物及び使用方法 |
CA2912801A1 (en) | 2013-05-17 | 2014-11-20 | Medimmune, Llc | Receptors for b7-h4 |
WO2017041053A1 (en) | 2015-09-04 | 2017-03-09 | Yale University | Polymeric bile acid nanocompositions targeting the pancreas and colon |
WO2017070676A1 (en) | 2015-10-23 | 2017-04-27 | Massachusetts Instittue Of Technology | Nanoparticles comprising a metal core surrounded by a monolayer for lymph node targeting |
BR112018069741A2 (pt) | 2016-04-04 | 2019-02-05 | Drug Delivery Solutions Ltd | composição para aplicação tópica, e, método para fabricar uma composição para aplicação tópica. |
KR20240035625A (ko) | 2016-09-21 | 2024-03-15 | 넥스트큐어 인코포레이티드 | Siglec-15를 위한 항체 및 이의 사용 방법 |
EP3542788A1 (de) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat |
EP3782627A4 (de) * | 2018-04-17 | 2021-07-07 | Shanghai Tonglian Pharmaceutical Co., Ltd. | Zur vorbeugung und/oder behandlung von schmerz und/oder fieber verwendetes arzneimittel, kombinationsprodukt und verwendung davon |
WO2019217661A1 (en) | 2018-05-09 | 2019-11-14 | Yale University | Compositions and systems for ex vivo cell modulation and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859782A (en) * | 1986-06-26 | 1989-08-22 | Harbor Branch Oceanographic Institution, Inc. | Misakinolide compositions and their derivatives |
WO1993007884A1 (en) * | 1991-10-25 | 1993-04-29 | Senju Pharmaceutical Co., Ltd. | External preparation for treating hemorrhoidal diseases |
JPH06345646A (ja) * | 1993-06-08 | 1994-12-20 | Fujisawa Pharmaceut Co Ltd | ローション剤 |
DK1147766T3 (da) * | 1994-10-26 | 2005-08-29 | Novartis Ag | Farmaceutiske sammensætninger |
-
1998
- 1998-07-06 GB GBGB9814640.0A patent/GB9814640D0/en not_active Ceased
-
1999
- 1999-07-02 JP JP2000557831A patent/JP2002519378A/ja not_active Withdrawn
- 1999-07-02 WO PCT/JP1999/003602 patent/WO2000001385A1/en active IP Right Grant
- 1999-07-02 DE DE69925488T patent/DE69925488T2/de not_active Expired - Fee Related
- 1999-07-02 EP EP99926921A patent/EP1093371B1/de not_active Expired - Lifetime
- 1999-07-02 ES ES99926921T patent/ES2239446T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69925488T2 (de) | 2005-11-17 |
ES2239446T3 (es) | 2005-09-16 |
EP1093371B1 (de) | 2005-05-25 |
JP2002519378A (ja) | 2002-07-02 |
GB9814640D0 (en) | 1998-09-02 |
EP1093371A1 (de) | 2001-04-25 |
WO2000001385A1 (en) | 2000-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69925488D1 (de) | Verwendung von fk506 und verwandten makroliden zur herstellung eines medikaments für die behandlung und vorbeugung von schmerzen | |
DE69934112D1 (de) | Implantierbarer gewebeverschluss und system zur behandlung gastroösophagischen rückflusses | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
ATE280580T1 (de) | Verwendung von annexin-modulatoren zur herstellung eines medikaments zur behandlung und/oder vorbeugung von arthritis und arthritischen erkrankungen | |
DE69822410D1 (de) | Modularkatheter zur Abbildung und Behandlung und Montageverfahren | |
DE69830728D1 (de) | Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz | |
DE60004974D1 (de) | Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen | |
DE69736585D1 (de) | Photokatalytischer formkörper und methode zu seiner herstellung | |
DE69918687D1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
DE69805438T2 (de) | Misch- und ladeöffnung zur medizinischen behandlung | |
DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
DE69630947D1 (de) | Mittel zur schmerzbehandlung | |
DE60022754D1 (de) | Diagnose und behandlung von arrhythmien | |
DE69824576D1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
DE50010284D1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
DE69532066D1 (de) | Arzneimittel zur Behandlung von Restenosis und Gefässsklerose | |
DE69620691T2 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
ATE246518T1 (de) | Egr-1 zur herstellung eines medikamentes zur behandlung von wunden | |
DE69635298D1 (de) | Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen | |
DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
DE69637449D1 (de) | Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen | |
ATE431142T1 (de) | Arzneimittel zur behandlung und vermeidung neurogener schmerzen | |
DE69825319D1 (de) | Präparat zur vorbeugung und behandlung von entzündungen | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |